Medinol goes after J&J's Cordis in stent patent war
Medinol, which wrung a $750 million patent infringement decision from Boston Scientific in 2005, sues Johnson & Johnson's Cordis stent making arm.
Cordis Corp., the stent-making arm of Johnson & Johnson  (NYSE:JNJ ), got out of the coronary stent game 2 years go, but that's not stopping Israeli medical device company Medinol from suing Cordis for patent infringement with the Cypher and Cypher Select stents it no longer makes.
Medinol, which won a $750 million decision over erstwhile partner Boston Scientific  (NYSE:BSX ) in 2005, accused Cordis in March of violating 4 of its patents with the Cypher stents, according to court documents and regulatory filings.
The lawsuit, filed in the U.S. District Court for Southern New York, seeks a jury trial, judgments of infringement and willful infringement, damages and triple damages for willful infringement, legal fees and pre- and post-judgment interest, according to the documents. The patents cited cover articulated stent technology.